Check4Cancer is delighted to have been shortlisted as finalist in three separate categories of the Laing Buisson healthcare awards for excellence 2017.
Rising Star - Professor Gordon Wishart, as Chief Medical Officer of Check4Cancer, has led the company to becoming an innovative private provider of early cancer detection services with cancer as its sole-focus and in doing so has created the perfect vehicle to make a major impact on early cancer detection in the UK.
Healthcare outcomes - Check4Cancer's tangible successes include the introduction of breast cancer and skin cancer self-referral diagnostic pathways ensuring fast and accurate diagnosis.
Innovation in technology - Check4Cancer's Cancer Impact Calculator, a custom-built model, helps employers to measure the impact of company-paid cancer screening for employees.
The awards will be presented on 15 November in London. LaingBuisson healthcare awards for excellence 2017
